BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3342375)

  • 1. Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase alpha.
    Mushika M; Miwa T; Suzuoki Y; Hayashi K; Masaki S; Kaneda T
    Cancer; 1988 Mar; 61(6):1182-6. PubMed ID: 3342375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity in dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix.
    Tanaka T
    Pathol Res Pract; 1986 Oct; 181(5):531-9. PubMed ID: 3786246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apoptosis and cell growth fraction in normal, dysplastic and neoplastic squamous epithelium of uterine cervix].
    Furuya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):141-8. PubMed ID: 7706854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
    Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
    Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
    Murakami T; Nagai N; Ota S; Ohama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium.
    Maruo T; Yamasaki M; Ladines-Llave CA; Mochizuki M
    Cancer; 1992 Mar; 69(5):1182-7. PubMed ID: 1739918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
    Harada K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the Oxford tumour marker in uterine cervical lesions.
    Beltrami CA; Di Loreto C; De Nictolis M; Stramazzotti D
    Appl Pathol; 1984; 2(1):39-42. PubMed ID: 6395880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of keratin subsets in normal and abnormal uterine cervical tissues. An immunohistochemical study.
    Malecha MJ; Miettinen M
    Int J Gynecol Pathol; 1992; 11(1):24-9. PubMed ID: 1373415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix.
    Maier RC; Norris HJ
    Obstet Gynecol; 1980 Sep; 56(3):361-4. PubMed ID: 7422175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
    Ueda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions.
    Shiratori Y; Soma Y; Maruyama H; Sato S; Takano A; Sato K
    Cancer Res; 1987 Dec; 47(24 Pt 1):6806-9. PubMed ID: 3499981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency and distribution of mitotic figures in dysplasia and carcinoma in situ.
    Chi CH; Rubio CA; Lagerlöf B
    Cancer; 1977 Mar; 39(3):1218-23. PubMed ID: 912655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of malignancy of severe dysplasia of the uterine cervix.
    Yajima A; Sato A; Mori T; Wakisaka T; Sato S; Suzuki M; Teshima K; Noda K
    Tohoku J Exp Med; 1982 Apr; 136(4):433-8. PubMed ID: 7101276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular changes in severe dysplasia of the uterine cervix progressing to malignancy.
    Yajima A; Higashiiwai H; Sato A; Watanabe M; Mori T; Yonemoto Y; Hoshi K
    Tohoku J Exp Med; 1979 Sep; 129(1):75-81. PubMed ID: 494259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viability of the human cervical epithelium with dysplasia and carcinoma in situ.
    Rubio CA; Lagerlöf B; Kock Y; Söderberg G; Thomassen P
    J Natl Cancer Inst; 1978 Mar; 60(3):523-6. PubMed ID: 625062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ) of the cervix].
    Heim K; Müller-Holzner E; Pinzger G; Holböck E; Wartusch B
    Gynakol Rundsch; 1989; 29 Suppl 2():407-9. PubMed ID: 2613064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphology and histogenesis of dysplasias of the cervix uteri].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1985; 47(11):32-7. PubMed ID: 4091694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.